Journal: Journal of Innate Immunity
Article Title: Regulation of Macrophage Cell Surface GAPDH Alters LL-37 Internalization and Downstream Effects in the Cell
doi: 10.1159/000530083
Figure Lengend Snippet: Surface GAPDH moonlights as an LL-37 receptor, internalizing it in a lipid raft-dependent process. a–c THP-1 empty vector and GAPDH knockdown cells were treated with IFNγ. Elevation of both cell surface GAPDH ( a ) and P2×7 levels ( b ) was confirmed by flow cytometry. Internalization of LL-37-FAM into these cells was quantified using flow cytometry and found to be sensitive to surface recruitment of GAPDH. c All data are presented as mean fluorescence intensity (MFI ± SEM) from 10 4 cells for n = 3 (*** p < 0.005, *** p < 0.0001, *** p < 0.001 and overlay is representative of three independent experiments). d , e Treatment with LL-37 results in elevated cytosolic Ca ++ levels. PMA-activated THP-1 cells were treated with LL-37 peptide (10 μg/mL) for 12 h and stained with 2 μ m fluo-3-AM for 30 min. Cells were visualized by confocal microscopy, representative image scale bars, 10 μm. d Cellular fluo-3-AM fluorescence was also quantified using flow cytometry, Ca ++ signal is not enhanced in GAPDH knockdown THP-1 cells. Flow cytometry data are presented as mean fluorescence intensity (MFI ± SEM), from 10 4 cells for n = 3 *** p < 0.0001 ( e ). f–h Inhibition of CaMK II with KN-62 results in inhibition of LL-37 uptake into J774 wild-type cells ( f ). This is accompanied with a decrease in cell surface GAPDH ( g ) and intracellular Ca 2+ levels ( h ). Data are shown as representative overlay histogram and are representative of three independent experiments and box plot in the inset is presented as mean fluorescence intensity (MFI ± SEM) from 10 4 cells with at least *** p < 0.005, n = 3. GAPDH and LL-37-FAM co-localize on macrophage plasma membrane ( i ). J774 cells were stained with polyclonal mouse anti-GAPDH antibody for 1 hour at 4°C; subsequently, after extensive washing, cells were incubated with anti-mouse Alexa 568 and 5 μg of LL-37-FAM. After 3 rinses, cells were shifted to 37°C for 20 min to allow for internalization of surface-bound molecules. Cells were then fixed and visualized under a confocal microscope. Scale bar, 5 μm. Pearson’s correlation coefficient was calculated to evaluate the extent of co-localization (*** p < 0.0001, n = 10). Co-IP assay revealed LL-37 interaction with membrane GAPDH (for detailed explanation of protocol, see online supplementary methods) ( j ). Disruption of membrane rafts on J774 plasma membrane by treatment with mevinolin (MEV) and methyl-β-cyclodextrin (MβCD) confirmed by significant loss of cholera toxin-B Alexa 647 binding using flow cytometry ( k ). Results in box plot are presented as MFI ± SEM from 10 4 cells (*** p < 0.001, n = 2). Binding of LL-37 and co-localization with GAPDH in lipid rafts was confirmed by confocal microscopy ( l , upper panel). Disruption of rafts resulted in decrease of, GAPDH signal as well as LL-37 binding ( l , lower panel). m–o Treatment of cells with IFNγ enhances GAPDH on membrane ( m ) which correlates with enhanced LL-37 binding ( n ) and uptake ( o ); disruption of rafts depletes surface GAPDH ( m ) with cells binding and internalizing significantly less of LL-37 ( n , o ). GAPDH expression, LL-37 binding, and internalization were evaluated by flow cytometry after IFNγ treatment and lipid raft disruption. Flow cytometry results are presented in box plot as MFI ± SEM from 10 4 cells (*** p < 0.001, n = 3). For gating strategy utilized in flow cytometry experiments, please see online supplementary Fig. S3. CaMK II, calmodulin-dependent kinase type II. IP, immunoprecipitation; IB, immunoblotting.
Article Snippet: To determine the signaling pathway for LL-37 induction or its internalization, cells were treated with 100 n m KN-62 (1-(N,O-bis(5-Isoquinolinesulfonyl)-N-methyl- l -tyrosyl)-4-phenylpiperazine), a P2RX7 receptor inhibitor for 4 h (Calbiochem), p38 mitogen-activated protein kinase (MAPK) inhibitor SB0502880 (Sigma) for 1 h, cholesterol synthesis inhibitor mevinolin and methyl-β-cyclodextrin (to disrupt membrane rafts) (Sigma) for 4 h, bafilomycin 100 nm alone for 2 h or before treatment with LL-37 (AnaSpec #AS-61302) or scrambled LL-37 (AnaSpec #AS-63708).
Techniques: Plasmid Preparation, Flow Cytometry, Fluorescence, Staining, Confocal Microscopy, Inhibition, Incubation, Microscopy, Co-Immunoprecipitation Assay, Binding Assay, Expressing, Immunoprecipitation, Western Blot